Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lenta's retail revenue in Q1 up 23%

4/28/25 LENT

MGKL reported for 2024 by IFRS

4/28/25 MGKL

MD Medical's revenues in Q1 grew by 17%

4/28/25 MDMG

Sberbank reports for 3 months of 2025 by IFRS

4/28/25 SBER

International Trade Center reported for 3 months of 2025 according to RAS

4/26/25 WTCM

Board of Directors of Rosneft Oil Company recommended that dividends be paid for 2024

4/25/25 ROSN

Positive Technologies reported for 3 months of 2025 by RAS

4/25/25 POSI

Moscow Exchange's Supervisory Board has set record date for dividend payments for 2024

4/25/25 MOEX

Shareholders of Bank St. Petersburg approved dividends for 2024

4/25/25 BSPB

NKHP reported for 3 months of 2025 by RAS

4/25/25 NKHP